Peptide Stack for Gut Repair: BPC-157, LL-37, and Leaky Gut Protocol

Intestinal permeability — commonly called "leaky gut" — sits at the intersection of autoimmune disease, chronic inflammation, anxiety, and fatigue. When tight junction proteins between intestinal epithelial cells degrade, bacterial fragments (lipopolysaccharides), food proteins, and other antigens cross into the bloodstream, triggering systemic immune activation.

Peptide therapy has emerged as one of the more targeted interventions for restoring gut barrier function and resolving the underlying inflammation. This protocol covers a structured 8–12 week approach using BPC-157 as the cornerstone, LL-37 for antimicrobial and barrier support, and practical adjuncts to maximize recovery.

Understanding the Gut Repair Target

Before stacking peptides, it helps to understand what needs repairing:

• Tight junctions: Protein complexes (occludin, claudin, zonulin) that seal gaps between epithelial cells
• Mucus layer: The protective glycoprotein barrier that keeps luminal bacteria away from epithelium
• Gut-associated lymphoid tissue (GALT): The immune tissue that must distinguish food from pathogens
• Microbiome: The bacterial ecosystem that produces short-chain fatty acids supporting barrier integrity

Peptides that target these structures can accelerate repair that diet and lifestyle interventions alone accomplish slowly.

Layer 1: BPC-157 (Foundation)

Body Protection Compound-157 is a 15-amino-acid synthetic peptide derived from a naturally occurring protein in human gastric juice. It is the most thoroughly studied gut-repair peptide, with research in rodent models documenting:

• Acceleration of intestinal anastomosis healing
• Upregulation of growth hormone receptor expression in gut tissue
• Reduction of NSAID-induced gut damage
• Promotion of angiogenesis (new blood vessel formation) at wound sites
• Modulation of the nitric oxide system to reduce inflammation

Protocol:

• Dose: 250–500 mcg per day
• Administration: Oral BPC-157 (capsule or dissolved in water) for GI-specific effects; subcutaneous injection for systemic effects — the oral route delivers higher concentrations directly to intestinal tissue
• Timing: On an empty stomach, ideally 30 minutes before the first meal
• Cycle: 8–12 weeks continuously; some protocols use 4 weeks on, 2 weeks off

Oral BPC-157 is the preferred delivery method specifically for gut repair because it passes through the GI tract and acts topically on the intestinal lining before systemic absorption. See our detailed BPC-157 guide for reconstitution and full reference dosing.

Layer 2: LL-37 (Antimicrobial and Barrier Support)

LL-37 is the only known human cathelicidin antimicrobial peptide. It is produced by intestinal epithelial cells, neutrophils, and natural killer cells as a first-line defense against pathogens. Its roles in gut health include:

• Directly killing gram-positive and gram-negative bacteria, fungi, and some viruses
• Modulating inflammatory cytokine production (reducing TNF-α and IL-6 signaling)
• Promoting epithelial migration and wound healing through EGFR (epidermal growth factor receptor) activation
• Reducing bacterial translocation across a compromised epithelial barrier

Deficient LL-37 expression has been found in patients with inflammatory bowel disease, Crohn's disease, and recurrent gut infections.

Protocol:

• Dose: 100–200 mcg per day
• Administration: Subcutaneous injection (LL-37 is degraded in the GI tract and must be injected for systemic effect)
• Timing: Morning, separate from BPC-157 if using both subcutaneously
• Cycle: 8 weeks; consider a 4-week break if using continuously

Layer 3: Glutamine (Supporting Adjunct)

L-Glutamine is the primary fuel source for intestinal enterocytes (gut lining cells) and is the most studied nutritional adjunct for leaky gut. Clinical trials show that 15–30 g/day of glutamine supplementation significantly reduces intestinal permeability markers, including zonulin levels, in patients with irritable bowel syndrome and increased permeability.

While not a peptide, glutamine works synergistically with BPC-157 by ensuring enterocytes have the substrate needed to proliferate and repair. It is included in this protocol as an essential supporting compound.

Protocol:

• Dose: 10–20 g per day
• Timing: Split into 2–3 doses, particularly on an empty stomach and before bed
• Form: Powder dissolved in water is most practical

The 8–12 Week Leaky Gut Protocol

Phase 1 (Weeks 1–4): Foundation and Reduction of Inflammation

Focus on establishing the peptide base while removing dietary triggers:

• Begin oral BPC-157 at 250 mcg/day; increase to 500 mcg at week 2 if well-tolerated
• Begin LL-37 at 100 mcg/day subcutaneously
• Glutamine: 10 g twice daily
• Remove gluten, dairy, refined sugar, and seed oils from diet (the four primary drivers of tight junction disruption)
• Add fermented foods or a high-quality probiotic (10–50 billion CFU/day)

Phase 2 (Weeks 5–8): Active Repair and Microbiome Restoration

• Continue BPC-157 at 500 mcg/day
• Continue LL-37 at 150–200 mcg/day
• Add short-chain fatty acid support: butyrate (600–1200 mg/day) — butyrate is the primary energy source for colonocytes and supports tight junction expression
• Reintroduce a limited food challenge to assess barrier progress: reintroduce one removed food category and monitor symptoms for 72 hours

Phase 3 (Weeks 9–12): Consolidation

• Taper BPC-157 to 250 mcg/day
• LL-37 at 100 mcg/day, 5 days per week
• Transition to maintenance probiotics and dietary adjustments
• Consider functional testing to assess progress (zonulin, calprotectin, comprehensive stool analysis)

Monitoring Progress

Gut repair is not always linear. Track:

• Symptom diary: Bloating, gas, stool consistency, energy, brain fog — score daily on a 1–10 scale
• Elimination patterns: Bowel movement frequency and consistency
• Systemic markers: If possible, retest zonulin (marker of intestinal permeability) and high-sensitivity CRP at 8 weeks
• Food reactivity: Note whether previously reactive foods produce less response as the barrier repairs

Patients with more advanced gut damage (confirmed by elevated zonulin, positive LPS antibodies, or severe inflammatory bowel conditions) may require 16+ weeks of consistent protocol.

What Drives Leaky Gut in the First Place

Repairing the gut without addressing root causes is temporary. The primary contributors to intestinal permeability include:

• Chronic NSAID use (ibuprofen, aspirin — these directly damage the intestinal lining)
• Alcohol consumption
• Chronic psychological stress (via the gut-brain axis and cortisol's effect on tight junctions)
• Dysbiosis (bacterial imbalance, SIBO)
• Processed food diet high in emulsifiers (polysorbate-80, carboxymethylcellulose)
• Proton pump inhibitor overuse
• Antibiotic overuse without probiotic restoration

For more on peptides that support this broader healing, see our guide to peptides for gut healing and peptides for the immune system.

Safety Considerations

BPC-157 has a remarkably clean safety profile in preclinical research with no identified toxic dose in animal studies. LL-37 is a naturally occurring human peptide, which limits immunogenicity concerns.

Practical cautions:

• LL-37 can cause mild injection site reactions (redness, brief soreness)
• Start low and observe for 3–5 days before increasing dose
• Those with active infections should consult a physician before using LL-37 (its immune-modulatory effects are bidirectional)

Frequently Asked Questions

Q: Should I use oral or injectable BPC-157 for gut repair? For specifically targeting the intestinal lining, oral delivery is more effective because the peptide contacts the gut tissue directly. Subcutaneous injections are better for systemic effects (joint healing, organ repair). Many practitioners use both simultaneously — oral for GI, injectable for systemic benefits.

Q: How long before I notice results from BPC-157? Most users report improvements in gut discomfort, bloating, and regularity within 2–4 weeks of daily oral BPC-157. More structural repair of the epithelial barrier takes 8–12 weeks. The speed of response correlates with severity of initial damage and compliance with dietary modifications.

Q: Can I use this stack alongside prescription medications for IBD? BPC-157 has been studied alongside standard IBD treatments in preclinical research without antagonism. However, given that it can modulate inflammatory pathways, coordinate with your gastroenterologist before combining with immunosuppressants like mesalamine or biologics.

Q: Is glutamine necessary or optional? Glutamine is a highly evidence-backed adjunct for gut repair and is inexpensive. Clinical trial data from the IBD population shows measurable improvements in barrier function markers. Treat it as essential rather than optional in this protocol.

Q: Will diet changes matter if I'm taking these peptides? Yes — substantially. BPC-157 and LL-37 accelerate repair, but if inflammatory dietary triggers remain active, you are repairing tissue that is being continuously damaged. The dietary component is not optional for lasting results.